小兒學科

Medicine & Life Sciences

1. Acinetobacter baumannii 8%
2. Adrenal Cortex Hormones 8%
3. Air 23%
4. Anti-Bacterial Agents 10%
5. Apoptosis 10%
6. Asthma 17%
7. Body Weight 10%
8. Brain 10%
9. Bronchoalveolar Lavage Fluid 7%
10. Bronchopulmonary Dysplasia 20%
11. Budesonide 11%
12. Caliciviridae Infections 9%
13. CAP18 lipopolysaccharide-binding protein 10%
14. Child 38%
15. Chronic Renal Insufficiency 7%
16. Cohort Studies 26%
17. Collagen 14%
18. Confidence Intervals 15%
19. Connective Tissue Growth Factor 15%
20. Control Groups 9%
21. Cytokines 9%
22. Databases 9%
23. Down-Regulation 9%
24. Epithelial-Mesenchymal Transition 7%
25. Epoprostenol 8%
26. Fetal Growth Retardation 10%
27. Fibrosis 20%
28. Gastroenteritis 12%
29. Gastrointestinal Diseases 7%
30. Gene Expression 8%
31. Genes 14%
32. Gestational Age 7%
33. Growth 8%
34. Half-Life 8%
35. Hemophilia A 41%
36. Hemorrhage 11%
37. Hyperoxia 80%
38. In Vitro Techniques 17%
39. Incidence 8%
40. Infections 10%
41. Inflammation 11%
42. Joint Diseases 7%
43. Kidney 24%
44. Klebsiella pneumoniae 14%
45. Lipopolysaccharides 13%
46. Lung 57%
47. Lung Injury 37%
48. Malnutrition 8%
49. Maternal Exposure 14%
50. Mesenchymal Stem Cells 15%
51. Meta-Analysis 10%
52. Methicillin-Resistant Staphylococcus aureus 7%
53. Mothers 26%
54. Mutation 12%
55. National Health Programs 11%
56. Neoplasms 16%
57. Neuroblastoma 18%
58. Newborn Infant 13%
59. Nicotine 14%
60. Norovirus 11%
61. Odds Ratio 8%
62. Oligohydramnios 19%
63. Oxidative Stress 11%
64. Paraquat 10%
65. Paraquat lung 8%
66. Parturition 7%
67. Pediatrics 25%
68. Pharmaceutical Preparations 9%
69. Phenotype 7%
70. Pneumonia 14%
71. Population 35%
72. Precursor Cell Lymphoblastic Leukemia-Lymphoma 14%
73. Pregnancy 18%
74. Pregnancy Outcome 9%
75. Premature Birth 8%
76. Premature Infants 16%
77. Proteins 10%
78. Renin-Angiotensin System 8%
79. Retrospective Studies 14%
80. Saline Solution 16%
81. Salmonella 7%
82. Seizures 17%
83. Serogroup 8%
84. Serum 8%
85. Sprague Dawley Rats 8%
86. Stem Cells 10%
87. Stroke 11%
88. Surface-Active Agents 24%
89. Systematic Reviews 9%
90. Taiwan 100%
91. Therapeutics 21%
92. thymic stromal lymphopoietin 7%
93. Tigecycline 21%
94. Up-Regulation 9%
95. Urinary Tract Infections 7%
96. Vascular Endothelial Growth Factor A 8%
97. Ventilation 8%
98. Ventilator-Induced Lung Injury 20%
99. Very Low Birth Weight Infant 9%
100. Wounds and Injuries 16%